Abbasinejads expertise in Obesity Medicine allows her to proactively manage these side effects so patients dont abandon treatment
The GLP-1 market has been periodically hampered by shortages, and Lilly is betting that putting the drug into this new form will allow them to produce a more robust supply
The clear timeline for each level gave me confidence and helped me manage expectations better than winging it
Zhou H, Ji L, Song X et al (2024) ZT002, a novel ultra long-acting GLP-1 receptor agonist in adults with overweight or obesity: a randomised, placebo-controlled, multiple ascending dose phase 1c study
This study analysed the effects of retatrutide on metabolic parameters and liver fat content, extending the research significance of this molecule beyond the regulation of glycaemia and energy balance alone
In DAPA-CKD, among 4,304 participants (67.5% with type 2 diabetes mellitus and 15.3% with prediabetes at baseline), the mean eGFR was 43.1 mL/min/1.73 m and the median UACR was 949 mg/g [47,52]